Clinical Trials Sponsored by B. Braun Melsungen AG

Total 81 results

B. Braun Melsungen AG

Recruiting

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Central Venous Catheter

Germany, Italy
B. Braun Melsungen AG

Terminated

Gelatin in ICU and Sepsis (GENIUS)

Hypovolemia

Spain, Austria, Germany, Czechia, France
B. Braun Melsungen AG

Withdrawn

Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon" (ProDect)

Anesthesia, Intravenous | Elective Surgical Procedures
B. Braun Melsungen AG

Completed

Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System

Intensive Care Patients

United Kingdom, Estonia, Denmark, Germany, Poland, Czech Republic, Italy, Spain, Sweden
B. Braun Melsungen AG

Completed

Use of a Modified Propofol Emulsion in Adults

Anesthesia

Germany
B. Braun Melsungen AG

Completed

Comparison of HES 130 in Balanced and in Unbalanced Solution

Decreased and Nonspecific Blood Pressure Disorders and Shock

China
B. Braun Melsungen AG

Completed

Usability of Blood Glucose Control With the Space TGC System in Medical ICU Patients (DELIOS 4)

Critical Illness

Switzerland
B. Braun Melsungen AG

Completed

Feasibility of Blood Glucose Control With the Space TGC System in Medical ICU Patients (DELIOS 01)

Critical Illness

Austria
B. Braun Melsungen AG

Completed

Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients

Surgery

Germany, Austria, Czech Republic, Italy, Netherlands
B. Braun Melsungen AG

Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) (SCORE)

Coronary Artery Disease | Myocardial Ischaemia

Germany
B. Braun Melsungen AG

Completed

The HOME Study (HPN With OMEGA-3) (HOME)

Patients Requiring Home Parenteral Nutrition

Netherlands, United Kingdom, France, Italy, Poland
B. Braun Melsungen AG

Completed

Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants

Preterm Infants | Parenteral Nutrition n-3 Fatty Acids

Germany
B. Braun Melsungen AG

Completed

Gelatines in Pediatric PatientS (GPS)

Treatment of Hypovolemia and Shock

Spain, Bulgaria, Germany, Italy, United Kingdom
B. Braun Melsungen AG

Completed

Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter (ConSeQuent)

Restenosis | Stenosis

Germany
B. Braun Melsungen AG

Completed

Acceptability Study on Nutricomp® Drink Plus Fibre in Adults (Fuchsia)

Adult Patients in Need of High-energy Oral Nutritional Supplementation

United Kingdom
B. Braun Melsungen AG

Terminated

Different Lipid Emulsions in Acute Lung Injury Patients

Parenteral Nutrition

Germany
B. Braun Melsungen AG

Completed

Efficacy and Safety of a Fish Oil Containing Lipid Emulsion

Parenteral Nutrition

China
B. Braun Melsungen AG

Completed

Feasibility of Tight Blood Glucose Control With the Space TGC System in Surgical ICU Patients (DELIOS 03)

Critical Illness

Germany
B. Braun Melsungen AG

Active, not recruiting

Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

Coronary Artery Disease

France
B. Braun Melsungen AG

Completed

Evaluation of Introcan Safety 3 Closed IV Catheter

Patients in Need for Intravenous Access

Germany
B. Braun Melsungen AG

Active, not recruiting

Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW) (CONSEQUENT)

Peripheral Arterial Occlusive Disease

Germany
B. Braun Melsungen AG

Completed

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Covid19

Germany
B. Braun Melsungen AG

Completed

Study Comparing the Handling of Two Peripheral IV Catheter Systems

Intravenous Access According to Instructions For Use

Germany
B. Braun Melsungen AG

Completed

Silver Graft All Comers Registry

Aneurysm | Graft Failure | Graft Infection

Germany
B. Braun Melsungen AG

Completed

Parenteral Nutrition With Intravenous and Oral Fish Oil for Intensive Care Patients

Critical Illness

Israel
B. Braun Melsungen AG

Completed

Plasma Volume Replacement (PVR) Therapy With Colloid and Crystalloid Solutions

Plasma Volume Replacement | Surgery of the Pancreatic Head

Germany
B. Braun Melsungen AG

Completed

Safety and Efficacy of Longterm HPN With Two Lipid Emulsions

Malnutrition

Germany
B. Braun Melsungen AG

Completed

Comparison of Two Gelatine Solutions

Hypovolemia

Germany
B. Braun Melsungen AG

Completed

Comparison of Three-chamber-bag Versus Compounded Bag

Parenteral Nutrition for Patients With Proven Insufficient Enteral Resorption

China
B. Braun Melsungen AG

Completed

Safety Profile of Hydroxyethyl Starch

Plasma Volume Replacement

Malaysia, China
B. Braun Melsungen AG

Completed

Feasibility of Blood Glucose Control With the Space TGC System in Postoperative Cardiac Surgery Patients in the ICU (DELIOS 02)

Critical Illness

United Kingdom
B. Braun Melsungen AG

Terminated

Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

Renal Insufficiency

Germany
B. Braun Melsungen AG

Completed

Blood Glucose Control Over an Extended Glucose Control Range in Postoperative Cardiac Surgery Patients in the Intensive Care Unit (Aldea_02)

Critical Illness

United Kingdom
B. Braun Melsungen AG

Completed

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)

Catheter Related Bloodstream Infection | Bacteriaemia

Czech Republic
B. Braun Melsungen AG

Completed

Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients (Aldea _01)

Critical Illness

Austria
B. Braun Melsungen AG

Completed

Effect of a Modified Propofol Preparation on Injection Pain During Induction of Anesthesia in Children

Anesthesia
B. Braun Medical LLC

Completed

Study on the Efficacy and Safety of Gelaspan

Hypovolemia

Russian Federation
B. Braun Medical UK Ltd.

Completed

Acceptability Study on Oral Nutrition Supplement (ONS)

Oral Nutritional Supplementation

United Kingdom
B. Braun Melsungen AG
CeGaT GmbH

Completed

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Germany
University of Ulm
B. Braun Melsungen AG

Completed

The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions (PEPCAD-CTO)

Coronary Artery Disease | Chronic Total Occlusion | Native Coronary Artery

Germany
University Hospitals, Leicester
B. Braun Melsungen AG

Completed

The Effect of Fish Oils on Human Hepatic Colorectal Metastases

Colorectal Liver Metastases

United Kingdom
University Hospital, Saarland
B. Braun Melsungen AG

Completed

P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses

In-Stent Restenosis

Germany
B. Braun Melsungen AG
Deaconess Hospital Mannheim

Completed

"All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended)

Peripheral Arterial Occlusive Disease

Germany
B. Braun Melsungen AG
Deaconess Hospital Mannheim

Completed

"All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE)

Peripheral Arterial Occlusive Disease

Germany
University of Helsinki
B. Braun Melsungen AG

Completed

Effect of Prime Solution on Fluid Balance After Open Heart Surgery

Valve Surgery | Coronary Artery Bypass Grafting

Finland
Universitätsklinikum Hamburg-Eppendorf
B. Braun Melsungen AG

Completed

Computerized Tight Glycemic Control in Cardiac Surgery

Hyperglycemia

Germany
University of Jena
B. Braun Melsungen AG

Completed

Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty (OCTOPUS-2)

Stable Angina | Coronary Stenosis

Germany
B. Braun Melsungen AG
Charite University, Berlin, Germany

Completed

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

Coronary Artery Disease (CAD)

Germany, Spain, Malaysia
B. Braun Melsungen AG
Ernst von Bergmann Hospital

Completed

Post Market Surveillance of SeQuent Please Neo With Scoring Balloon (PASSWORD)

Coronary Artery Disease (CAD)

Germany
University of Ulm
B. Braun Melsungen AG; OrbusNeich

Completed

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries

Coronary Artery Disease

Germany

Clinical Trials Sponsored by B. Braun Melsungen AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations